|
|
|
|
| LEADER |
01000cas a22002652 4500 |
| 001 |
DOAJ078621577 |
| 003 |
DE-627 |
| 005 |
20240412065857.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
230307c20229999xx u| |o 0 |0eng c |
| 022 |
|
|
|a 24740896
|
| 035 |
|
|
|a (DE-627)DOAJ078621577
|
| 035 |
|
|
|a (DE-599)DOAJb13b52838040443ea00cfc43fb9b9121
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a British Journal of Biomedical Science
|
| 264 |
3 |
1 |
|b Frontiers Media S.A.
|c 2022-
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 540 |
|
|
|a CC BY
|
| 650 |
|
4 |
|a disease diagnosis
|
| 650 |
|
4 |
|a disease prevention
|
| 650 |
|
4 |
|a disease management
|
| 650 |
|
4 |
|a in vivo studies
|
| 650 |
|
4 |
|a in vitro studies
|
| 650 |
|
4 |
|a human disease
|
| 650 |
|
4 |
|a Therapeutics. Pharmacology
|
| 650 |
|
4 |
|a RM1-950
|
| 856 |
4 |
0 |
|u https://doaj.org/toc/2474-0896
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/for-authors/author-guidelines
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/for-authors/publishing-fees
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/about
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/about#about-4
|x Verlag
|z kostenfrei
|
| 856 |
4 |
0 |
|u https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science
|x Verlag
|z kostenfrei
|
| 912 |
|
|
|a GBV_DOAJ
|
| 951 |
|
|
|a JT
|
